Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.8580
+0.0015 (0.18%)
At close: Jan 16, 2026, 4:00 PM EST
0.8475
-0.0105 (-1.22%)
After-hours: Jan 16, 2026, 7:21 PM EST
Citius Pharmaceuticals Stock Forecast
CTXR's stock price has decreased by -74.76% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Citius Pharmaceuticals stock has a target of 6.00, which predicts a 599.30% increase from the current stock price of 0.86.
Price Target: $6.00 (+599.30%)
Analyst Consensus: Buy
* Price targets were last updated on Dec 4, 2025.
Analyst Ratings
The average analyst rating for Citius Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +599.30% | Dec 4, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +599.30% | Aug 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +599.30% | Jun 30, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +599.30% | Jun 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +948.95% | Jun 9, 2025 |
Financial Forecast
Revenue This Year
65.10M
Revenue Next Year
161.16M
from 65.10M
Increased by 147.57%
EPS This Year
0.37
from -3.38
EPS Next Year
2.29
from 0.37
Increased by 523.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 82.2M | 180.9M | |||
| Avg | 65.1M | 161.2M | |||
| Low | 48.4M | 140.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 177.8% | |||
| Avg | - | 147.6% | |||
| Low | - | 116.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.00 | 3.26 | |||
| Avg | 0.37 | 2.29 | |||
| Low | -0.61 | 1.36 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 786.4% | |||
| Avg | - | 523.6% | |||
| Low | - | 271.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.